Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
Sun N, Shen C, Zhang L, Wu X, Yu Y, Yang X, Yang C, Zhong C, Gao Z, Miao W, Yang Z, Gao W, Hu L, Williams K, Liu C, Chang Y, Gao Y.
Sun N, et al. Among authors: gao w, gao z, gao y.
Gut. 2021 Nov;70(11):2183-2195. doi: 10.1136/gutjnl-2020-321774. Epub 2020 Nov 30.
Gut. 2021.
PMID: 33257471
Free PMC article.